Sutro Biopharma Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $6.13 on 03/28/24 and the lowest value was $2.01 on 11/13/23.
52-week price history of STRO Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Sutro Biopharma Inc’s current trading price is -42.09% away from its 52-week high, while its distance from the 52-week low is 77.06%. The stock’s price range during this period has spanned from $2.01 to $6.13. In the Healthcare sector, the Sutro Biopharma Inc’s shares surpassed a trading volume of approximately 1.24 million for the day, which was noticeably higher compared to the average daily volume of 9.0.59 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Sutro Biopharma Inc (STRO) has experienced a quarterly rise of 8.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 317.83M and boasts a workforce of 302 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.75, with a change in price of -0.27. Similarly, Sutro Biopharma Inc recorded 689,646 in trading volume during the last 100 days, posting a change of -7.07%.
Examining STRO’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for STRO stands at 1.25. Similarly, the long-term debt-to-equity ratio is also 1.21.
STRO Stock Stochastic Average
Today’s raw stochastic average for Sutro Biopharma Inc over the last 50 days is 16.92%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 45.21%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 30.65% and 34.37%, respectively.
STRO Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -17.25% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -7.31%. Over the past 30 days, the price of STRO has fallen by 0.57%. And in the last five days, it has surged by 2.90%.
